Nemes Rush Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.2M Buy
91,397
+2,172
+2% +$506K 1.92% 13
2026
Q1
$21.8M Sell
89,225
-7,231
-7% -$1.68M 2.07% 11
2025
Q4
$20M Buy
96,456
+1,327
+1% +$262K 1.88% 12
2025
Q3
$17.6M Buy
95,129
+1,399
+1% +$240K 1.75% 17
2025
Q2
$14.3M Buy
93,730
+31,851
+51% +$4.9M 1.56% 21
2025
Q1
$10.3M Buy
61,879
+5,925
+11% +$927K 1.3% 28
2024
Q4
$8.09M Buy
55,954
+7,114
+15% +$1.1M 1% 32
2024
Q3
$7.73M Sell
48,840
-2,429
-5% -$387K 1.12% 32
2024
Q2
$7.49M Buy
51,269
+2,171
+4% +$323K 1.03% 35
2024
Q1
$7.77M Sell
49,098
-5,043
-9% -$803K 1.11% 32
2023
Q4
$8.49M Sell
54,141
-4,039
-7% -$619K 1.37% 25
2023
Q3
$9.06M Buy
58,180
+1,833
+3% +$302K 1.64% 19
2023
Q2
$9.33M Buy
+56,347
New +$9.09M 1.64% 20

Other funds holding JNJ

Nemes Rush Group's JNJ Position: Q2 2026 in Review

Nemes Rush Group increased its Johnson & Johnson (JNJ) stake by 2.4% in Q2 2026, buying an estimated $506K and bringing the position to 91,397 shares worth $23.2M. The position accounts for 1.92% of the portfolio, ranked #13.

Nemes Rush Group first reported a position in JNJ in Q2 2023 and has held it in 13 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Nemes Rush Group held 91,397 shares of Johnson & Johnson worth $23.2M as of Q2 2026.
  • Nemes Rush Group bought 2,172 Johnson & Johnson shares in Q2 2026, an estimated $506K.
  • Johnson & Johnson made up 1.92% of Nemes Rush Group's portfolio in Q2 2026, its #13 holding.
  • Nemes Rush Group first reported a position in Johnson & Johnson in Q2 2023 and has held it in 13 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.